ReCode LAB

We focus on reprogramming the immune microenvironment to address intractable diseases.

Our goal is to overcome therapeutic resistance and restore immune balance through innovative and multidisciplinary approaches.

To achieve this, we develop advanced delivery platforms—such as extracellular vesicles (EVs), antibody-drug conjugates (ADCs), peptide-drug conjugates (PDCs), and lipid nanoparticles (LNPs)—that enable the precise and efficient delivery of small molecules and nucleic acids to target cells and tissues.
We also harness molecular tools like PROTACs, microRNAs (miRNAs), small interfering RNAs (siRNAs), and messenger RNAs (mRNAs) to fine-tune gene expression and protein activity.

By integrating these technologies, we develop targeted therapies for hard-to-treat diseases by reprogramming cellular functions and immune responses.